Hong Kong Exchange filings show that on September 4, Lazard Asset Management LLC increased its holdings in SINOPHARM (01099) by 959,600 shares, at an average price of HK$15.6782 per share, for a total transaction value of approximately HK$15.04 million.
Following the acquisition, the fund's latest share count stands at roughly 188 million shares, representing a 14% ownership stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.